Protecting Oneself from Human Immunodeficiency Virus: Are Prevention Messages Being Heard?

Clinical Infectious Diseases

Volumn 37, Issue 12 SUPPL. 5, 2003, Pages

  Bell, David C ^a   Mosier, Victoria ^a   Atkinson, John S ^a  

^a Affiliated Systems Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DRUG ABUSE; FEMALE; HEALTH EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROLOGY; SEXUAL BEHAVIOR; SEXUALITY; URBAN AREA; VIRUS TRANSMISSION;

AWARENESS; COMMUNICATION; HIV; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; PATIENT EDUCATION; RISK-TAKING; SAFE SEX; SEXUAL PARTNERS;

EID: 0346218065     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/377544     Document Type: Article

References (30)

1. Des Jarlais DC, Friedman SR, Sotheran JL, Stoneburner R. The sharing of drug injection equipment and the AIDS epidemic in New York City: the first decade. NIDA Res Monogr 1988; 80:160-75.
2. Neaigus A, Friedman SR, Jose B, et al. High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 11:499-509.
3. Woodhouse DE, Rothenberg RB, Potterat JJ, et al. Mapping a social network of heterosexuals at high risk for HIV infection. AIDS 1994; 8:1331-6.
4. Bell DC, Trevino RA. Modeling HIV risk. J Acquir Immune Defic Syndr 1999; 22:280-7.
5. Friedman SR, Curtis R, Neaigus A, Jose B, Des Jarlais DC. Social networks, drug injectors' lives, and HIV/AIDS. New York: Kluwer Academic/Plenum, 1999.
6. Klovdahl AS. Social networks and the spread of infectious diseases: the AIDS example. Soc Sci Med 1985; 21:1203-16.
7. Potterat JJ, Rothenberg RB, Muth SQ. Network structure dynamics and infectious disease propagation. Int J STD AIDS 1999; 10:182-5.
8. Rothenberg RB, Woodhouse DE, Potterat JJ, et al. Social networks in disease transmission: the Colorado Springs Study. NIDA Res Monogr 1995; 151:3-19.
9. Trotter RT II, Bowen AM, Potter JM Jr. Network models for HIV outreach and prevention programs for drug users. NIDA Res Monogr 1995; 151:144-80.
10. Wasserman S, Faust K. Social network analysis: methods and applications. Cambridge, UK: Cambridge University Press, 1994.
11. Williams ML, Zhao Z, Bowen AM, Freeman RC, Elwood WN, Rusek R. Introduction of HIV into drug injector networks outside AIDS epicenters. Int J STD AIDS 1997; 8:629-35.
12. City of Houston and Harris County Texas. Epidemiology of sexually transmitted diseases: chlamydia, gonorrhea, syphilis 1991-2000, HIV/AIDS 1981-2000. Houston: Houston Department of Health and Human Services Bureau of HIV/STD Prevention, 2000:1-91.
13. Dolezal C, Meyer-Bahlburg HF, Liu X, et al. Longitudinal changes in sexual risk behavior among HIV+ and HIV-male injecting drug users. Am J Drug Alcohol Abuse 1999; 25:281-303.
14. Padian NS, Shiboski SC, Glass SO, Vittinghoff E. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. Am J Epidemiol 1997; 146:350-7.
15. Booth RE. Predictors of unsafe needle practices: injection drug users in Denver. J Acquir Immune Defic Syndr 1994; 7:504-8.
16. Longshore D, Anglin MD. Intentions to share injection paraphernalia: an empirical test of the AIDS risk reduction model among injection drug users. Int J Addict 1995; 30:305-21.
17. Bell DC, Atkinson JS, Mosier V. The role of gatekeepers in limiting HIV transmission. Int J Sociol and Soc Policy 2002; 22:47-76.
18. Bell DC, Montoya ID, Atkinson JS. Partner concordance in reports of joint risk behaviors. I Acquir Immune Defic Syndr 2000; 25:173-81.
19. Bell DC, Montoya ID, Atkinson JS, Yang S-J. Social networks and forecasting the spread of HIV infection. J Acquir Immune Defic Syndr 2002; 31:218-29.
20. Allard R. A mathematical model to describe the risk of infection from sharing injection equipment. J Acquir Immune Defic Syndr 1990; 3:1010-6.
21. Allard R. A family of mathematical models to describe the risk of infection by a sexually transmitted agent. Epidemiology 1990; 1:30-3.
22. Friedman SR, Kottiri BJ, Neaigus A, Curtis R, Vermund SH, Des Jarlais DC. Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation. Am J Epidemiol 2000; 152:913-22.
23. Koopman JS, Jacquez JA, Welch GW, et al. The role of early HIV infection in the spread of HIV through populations. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:249-58.
24. Särndal CE, Swensson B, Wretman J. Model assisted survey sampling. New York: Springer-Verlag, 1992.
25. Elwood WN, Ataabadi AN. Influence of interpersonal and mass-mediated interventions on injection drug and crack users: diffusion of innovations and HIV risk behaviors. Subst Use Misuse 1997; 32:635-51.
26. Coyle SL. The NIDA standard intervention model for injection drug users not in treatment. Rockville, MD: National Institute on Drug Abuse, 1992.
27. Watters JK, Biernacki P. Targeted sampling: options for the study of hidden and elusive populations. Soc Probl 1989; 36:416-30.
28. Morris M, Dean L. Effect of sexual behavior change on long-term human immunodeficiency virus prevalence among homosexual men. Am J Epidemiol 1994; 140:217-32.
29. Hyman JM, Stanley EA. A risk-based heterosexual model for the AIDS epidemic with biased sexual partner selection. In: Kaplan EH, Brandeau ML, eds. Modeling the AIDS epidemic: planning, policy, and prediction. New York: Raven Press, 1994:331-63.
30. Centers for Disease Control and Prevention. US HIV and AIDS cases reported through December 1999. HIV AIDS Surveill Rep 1999; 11:1-44. Available at: http://www.cdc.gov/hiv/stats/hasr1102.htm